ロード中...
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
It is estimated that 10–20% of patients with pancreatic cancer present with resectable disease. Although surgery offers curative intent, the median survival following curative resection is less than 2 years. To improve clinical outcomes in this patient population, clinical studies have investigated...
保存先:
| 出版年: | Hematol Oncol Clin North Am |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699862/ https://ncbi.nlm.nih.gov/pubmed/26226906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2015.04.011 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|